Main content

    Ovarian Cancer Clinical Trials

    CPMC Cancer Services

    Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at ClinicalTrials.gov


    Active Trials

    Title: A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer
    Description: Study for Women With Platinum Sensitive Ovarian Cancer Evaluating Niraparib as Maintenance Therapy
    Investigator: John Chan, MD
    Eligibility: Subjects with platinum sensitive ovarian cancer who completed at least 2 lines of platinum therapy
    Status: Active and open to enrollment
    Contact: Lilian Hu, MPH, 415-600-3241 Email: HuLH@cpmcri.org about Study Tesaro PR-30-5011-C

    Title: A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®) in Combination Versus PLD in Participants With Platinum-Resistant Ovarian Cancer
    Description: Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Investigator: Ari Baron, MD
    Eligibility: Subjects with platinum-resistant ovarian cancer
    Status: Active and open to enrollment
    Contact: Lilian Hu, MPH, 415-600-3241 Email: HuLH@cpmcri.org about Study Endocyte EC-FV-06

    • updated April 2014

    Back to top